Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 9550772 Azaindole derivatives as multi kinase inhibitors

Patent 9550772 was granted and assigned to Oribase Pharma on January, 2017 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Applicant

0

Current Assignee

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Abdelaziz Yasri0

Bénédicte Dayde-Cazals0

Bénédicte Fauvel0

Cédric Bories0

Gwénaël Cheve0

Date of Patent

January 24, 2017

0

Patent Application Number

146556090

Date Filed

December 30, 2013

0

Patent Citations Received

US Patent 11851434 Substituted pyrazolo[1,5-A]pyrazine compounds as ret kinase inhibitors

0

US Patent 11998545 Substituted pyrazolo[1,5-a]pyridine compounds as RET kinase inhibitors

0

US Patent 11964988 Fused heterocyclic compounds as RET kinase inhibitors

0

Patent Primary Examiner

Niloofar Rahmani

0

Patent abstract

The present invention relates to compounds of the following formula (I) and/or the pharmaceutically acceptable addition salts, solvates, enantiomers, diastereoisomers thereof, as well as mixtures thereof. The subject matter of the present invention thus also includes the preparation of compounds of formula (I), their uses, in particular in the inhibition of protein kinases which are implicated for example in numerous diseases such as cancers or immune system disorders.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 9550772 Azaindole derivatives as multi kinase inhibitors

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool